Michael E Metzger, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3 Terrascape Pkwy, Somersworth, NH 03878 Phone: 603-609-6726 Fax: 603-609-6727 |
News Archive
The Bay Area Lyme Foundation today announced the first annual Bay Area Lyme Foundation 'Emerging Leader Award' and a $100,000 grant which will be given to a promising scientist who embodies the future of leadership in Lyme disease research.
Wellness Center USA, Inc., a Schaumburg IL based healthcare and nutraceutical company, reported the closing of its Psoria-Shield Inc. (PSI) acquisition. PSI is a Tampa, FL based developer and manufacturer of UltraViolet (UV) phototherapy devices for the treatment of skin diseases.
Clinigen Group plc today announced the acquisition of Cardioxane (dexrazoxane) from Novartis for US$33 million in cash, payable in two tranches.
Antibiotics are among the most important discoveries of modern medicine and have saved millions of lives since the discovery of penicillin almost 100 years ago.
People who have recovered from COVID-19 had a robust antibody response after the first mRNA vaccine dose, but little immune benefit after the second dose, according to new research from the Penn Institute of Immunology. The findings, published today in Science Immunology, suggest only a single vaccine dose may be needed to produce a sufficient antibody response.
› Verified 6 days ago